Navigation Links
Actemra in Medical News

Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012

Recent Entrants Invest Heavily in Promotion to Capture Share in Mature Market, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues,...

Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis

However, Pharmacy Directors Disagree About Formulary Inclusion for Key Emerging Biologic Agents That Will Launch for the Disease in the Next Few Years, According to a New Report from Decision Resources WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leadi...

Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis

The first Phase III study involving the use of Actemra in the treatment of rheumatoid arthritis has revealed that it is superior to conventional treatment modality that uses disease modifying anti-rheumatic drugs (DMARDs to inhibit // joint destruction. It has also been found to provide symptomatic...

Does the Crowded TNF Market Really Need Two New Agents? Rheumatologists Provide Insight in the Wave One Report of LaunchTrends(TM): SIMPONI and CIMZIA

...he established TNFs (Enbrel, Humira, and Remicade) which have been the target of Cimzia and Simponi's launches, the survey respondents anticipate that actemra would be most likely to replace BMS's Orencia in their practices. LaunchTrends (TM) measure launch effectiveness of new products from FDA appr...

ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress

...f Phase III clinical studies highlight benefits of actemra as a treatment for rheumatoid arthritis - NUT... About ACTEMRA(R) (tocilizumab) actemra is the first humanized interleukin-6 (IL-6) recept...nd have reported meeting their primary endpoints. actemra is currently under review by the FDA in the United...

FDA Advisory Committee Recommends Approval of ACTEMRA(R) (tocilizumab) for the Treatment of Rheumatoid Arthritis

...ommittee, we are hopeful that the FDA will approve actemra for the treatment of RA and provide a new option t...nt program was designed to evaluate the effects of actemra on signs and symptoms of RA, physical function, pr...(TNF) therapy, and one monotherapy study comparing actemra to methotrexate, a current standard of care, was a...

Roches Arthritis Drug Successful in III Stage Trail

... Roche Holding AG says that arthritis drug actemra has proved successful in a phase III clinical study. actemra helps relieve symptoms of rheumatoid arthritis in...eeks with 498 patients with difficult-to-treat RA. actemra was given in combination with a standard treatment...

New Drug for Rheumatoid Arthritis Looks Promising.

...y. Drug maker Roche Holding AG will file the drug actemra for regulatory approval in Europe and the U.S. lat...ntrolled by Roche. Roche owns the rights to market actemra outside Japan. Two other drugs rituxima...d to disability. The new treatment option actemra in combination with traditional drugs achieved a s...
Actemra in Medical Technology

International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet

- By targeting interleukin-6 receptors, ACTEMRA provides significant benefits for patients when compared with existing therapies - NUTLEY, N.J., March 20 /PRNewswire/ -- Patients with rheumatoid arthritis treated with Roche's ACTEMRA(TM) (tocilizumab) experienced significant and rapid re...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

... - Additional data reinforce long-term efficacy of actemra across a broad range of rheumatoid arthritis patie...ng with additional studies that support the use of actemra as a long-term treatment option for patients with ...30 percent and 47 percent of patients treated with actemra 4 mg/kg and 8 mg/kg, respectively, compared with 8...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

... - Fifth International Phase III actemra Study Meets its Primary Endpoints - NUTLEY, N...RA). The study also showed that patients receiving actemra experienced improved physical function, as measure...fth international Phase III study in the extensive actemra clinical development program to successfully meet ...

Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)

...health care professionals prescribe and administer actemra correctly, and that patients understand the potent...animal model data, beyond what was included in the actemra BLA. Roche is performing the requested pre-clinica...s to confirm the published literature showing that actemra does not affect peri- and post-natal development, ...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

...mproved physical function in patients treated with actemra - NUTLEY, N.J., Oct. 25 /PRNewswire/ -- One-year... "The LITHE study demonstrated that treatment with actemra inhibited structural joint damage, which is a majo...erosion and joint space narrowing, was lower among actemra (8 mg/kg and 4 mg/kg) plus methotrexate-treated pa...

ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments

...ions, along with 13 other abstracts which evaluate actemra in patients with moderately to severely active RA,...studies further support the efficacy and safety of actemra as a potential new treatment option for managing t... The AMBITION study, which examined the effects of actemra (8 mg/kg) as monotherapy, showed that 70 percent o...

ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies

... - Phase III monotherapy study shows actemra is first and only biologic to demonstrate statis... showed that significantly more patients receiving actemra achieved a 20 percent improvement in their signs a...r at week 24. In addition, nearly one-third of all actemra patients from both studies reached disease remissi...

New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients

...e LITHE study is the fifth international Phase III actemra trial to successfully meet its primary endpoints i...that a greater proportion of patients treated with actemra (4 mg/kg or 8 mg/kg) plus methotrexate versus plac...ent of the patients were from the United States. actemra was generally well tolerated; the most common adve...

Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis

...evere rheumatoid arthritis (RA). "The filing for actemra represents a significant milestone for Roche, and ...ombie, President and CEO, Hoffmann-La Roche Inc. actemra is the first humanized interleukin-6 (IL-6) recept...international Phase III studies which demonstrated actemra as monotherapy or in combination with disease modi...

Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms

...toms achieved with the unique inhibiting action of actemra that specifically targets interleukin-...the findings of this new TOWARD data which suggest actemra plus DMARDs demonstrates significant improvement i...rom both studies further establish the efficacy of actemra and confirm that inhibiting interleukin-6 (IL-6) r...
Actemra in Biological News

New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis

The innovative new rheumatoid arthritis drug Actemra (tocilizumab) has been shown to significantly improve the signs and symptoms of rheumatoid arthritis (RA) in patients who failed to achieve an adequate response to traditional disease modifying agents (DMARDs). Exciting new data from the TOWARD1...
Actemra in Biological Technology

Baseline Research Indicates High Interest in Centocor-Ortho Biotech's SIMPONI(R)

...of other late stage biologics awaiting approval such as UCB's CIMZIA(R) and Roche's ACTEMRA(R). 62% of the respondents reported a greater interest in actemra compared to SIMPONI, primarily due to ACTEMRA's novel mechanism of action. Given a choice between SIMPONI and CIMZIA, the respondents reported a grea...

ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting

... - Phase III data highlight the benefits of actemra for rheumatoid arthritis - NUTLEY, N.J., Oct. 20...ing results from the extensive multi-national actemra clinical development program, which included ...atients in 41 countries, including the U.S. About actemra (tocilizumab) ...

Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

...ol-Myers Squibb); MabThera (rituximab; Roche/Biogen/Genentech); methotrexate (generic); denosumab (Amgen); golimumab (Centocor/Schering-Plough/Essex); actemra (tocilizumab; Roche/Chugai); Cimzia (certolizumab; UCB); GA101 (anti-BR3-Fc/anti-BR3 MAb Biogen/Genentech); LymphoStat-B(R) (belimumab; Human Genome S...
Other Tags
(Date:7/14/2014)... Carepoint has been designed specifically to facilitate ... intuitive interface for recording, sending, displaying and receiving ... reporting features. , Hall mc - an Ontario-based ... Rebecca de Witte to create this exciting new ... Carepoint provides seamless, real-time communication between the ...
(Date:7/14/2014)... COPENHAGEN Participation in activities that promote mental ... may help protect against the development of Alzheimer,s ... new research reported today at the Alzheimer,s Association ... , Research reported at AAIC 2014 also showed ... post-traumatic stress disorder (PTSD) may increase dementia ...
(Date:7/14/2014)... 2014 Spine Team Texas ... care—from diagnosis to treatment and recovery. Currently all physical ... in or training for certification in The McKenzie Method. ... completed the extensive program. , “We require certification of ... results in better outcomes for spine pain patients,” said ...
(Date:7/14/2014)... July 14, 2014 Cadeon Associates ... Turning Information into Money,” today announced that it ... global program that helps partners resell, deploy, and ... Spotfire® analytics platform. TIBCO Software Inc. is a ... including TIBCO Spotfire analytics, providing businesses the ability ...
(Date:7/13/2014)... Recently, TopDresses100.com, a popular dress company in the ... multi-colored Quinceanera dresses to its product line. According ... outfits are guaranteed to be quality made. Now, they ... , TopDresses100.com has a wide variety of elegant dresses ... are in stock and ready to ship. As an ...
Breaking Medicine News(10 mins):Health News:Home Health Care Professional and Marketing Firm Team Up to Create New Homecare Communication App 2Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 2Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 3Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 4Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 5Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 6Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3Health News:Cheap Multi-colored Quinceanera Dresses From TopDresses100.com 2
(Date:7/11/2014)... Using spider toxins to study the proteins that let ... say they have stumbled upon a biological tactic that ... insect plagues in a safe and environmentally responsible way. ... be lethal for one species and harmless for a ... target specific pests without harming beneficial species like bees. ...
(Date:7/10/2014)... June 27, 2014  The American Academy of ... of Standards and Technology (NIST) and the Department ... research and forensic science expert members to the ... an element of the NIST,s Organization of Scientific ... the first appointments made to the new FSSB ...
(Date:7/10/2014)... 1, 2014 Smart technology emphasis grows ... and improved security: NXT-ID, Inc. (OTCBB: NXTD), eBay Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Visa Inc. ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ... the second series of 30 second spots on CNBC for ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
Other Contents